Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Trends shaping the IVD demand in emerging markets Clearstate’s latest infographic looks at the micro and… In-vitro diagnostics | Global
Trends shaping the IVD demand in emerging markets – thank you Clearstate’s latest infographic looks at the micro and… In-vitro diagnostics | Global
Growth opportunities for IVD companies in APAC and LATAM Growth opportunities from covid-19 have helped fuel rapid… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Point-of-care testing (POCT) | Tissue Diagnostics (TDx) | Americas | Asia
How impactful is your exhibitor booth going to be at AACC? Navigating the complex dynamics of conference exhibitions is… In-vitro diagnostics | Uncategorised | Global | IVD Gateway | LabPRO Plus | Size and Share Plus
Six facts to know about Australia’s infectious disease market Infectious disease testing in Australia is undergoing major… In-vitro diagnostics | Infectious Diseases Testing Monitor | Tissue Diagnostics (TDx) | Global
Six facts to know about Australia’s infectious disease market thank you page Infectious disease testing in Australia is undergoing major… In-vitro diagnostics | Infectious Diseases Testing Monitor | Tissue Diagnostics (TDx) | Asia
Driving better diagnostic discovery for patients with Rebecca Middleton, vice chair of the participant panel at Genomics England The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Enabling faster diagnosis of rare diseases: Interview with HBA Support’s Rebecca Middleton As global research and the understanding of genomics grows… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
The future of thalassemia care The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | IVD Gateway | Next Generation Sequencing (NGS)
Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
Uncovering opportunities faster with IVD Size & Share Plus In dynamic market segments such as infectious disease… In-vitro diagnostics | Global | IVD Gateway | Size and Share Plus
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now